XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Revenue $ 249,040
Cost of sales 200,129  
Gross Profit 48,911
Operating expenses:    
Research and development 4,152,152 1,147,955
General and administrative 4,763,114 1,792,482
Marketing and business development 451,421 289,726
Total operating expenses 9,366,687 3,230,163
Operating loss (9,317,776) (3,230,163)
Other income (expense):    
Interest expense, net of amortization of premium (367,459)
Impairment of property and equipment (237,309)
State grant income 75,000
Other income, net 258,137 34,324
Total other income (expense), net 20,828 (258,135)
Net loss $ (9,296,948) $ (3,488,298)
Net loss per share - Basic and diluted (in Dollars per share) $ (0.46) $ (0.41)
Weighted average common shares outstanding:    
Basic and diluted (in Shares) 20,163,915 8,522,422